Linden Advisors’s Zoetis ZTS Stock Holding History

Linden Advisors’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-255,200	Closed	-$32.1M	–	565
2025 Q4	$32.1M	Buy	+255,200	New	+$33.3M	0.2%	104

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Linden Advisors's ZTS Position: Q1 2026 in Review

Linden Advisors sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 255,200 shares — an estimated $32.1M sold.

Linden Advisors first reported a position in ZTS in Q4 2025 and held it in 1 quarter. The position peaked at $32.1M in Q4 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

Linden Advisors reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
Linden Advisors sold 255,200 Zoetis shares in Q1 2026, an estimated $32.1M.
Linden Advisors first reported a position in Zoetis in Q4 2025 and held it in 1 quarter.
Linden Advisors's Zoetis position peaked at $32.1M in Q4 2025.
1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.